Related by context. Frequent words. (Click for all words.) 73 Mln Common 72 Annual Meeting Date 72 Private Placement Financing 72 Mechel Announces 71 Vertex Pharmaceuticals Announces 71 Offering Quick Facts 71 Announces Non Brokered 70 IIROC Resume 70 Previously Announced 70 Completes Financing 70 Completes Private Placement 70 FY# Guidance 70 Common Share Offering 70 Final Tranche 69 Closes Private Placement 69 Closes Financing 69 Releases Third Quarter 69 Releases Second Quarter 69 Declares Quarterly Distribution 69 Provides Operational Update 69 Million Bought Deal 69 Grants Options 69 Flow Through Financing 68 Stock Repurchase 68 Dividend Announcement 68 Private Placement Offering 68 Mln Shares 68 Debt Tender Offer 68 Share Buyback Program 68 Declares Monthly Distribution 68 Fourth Quarter Dividend 68 Commence Trading 68 Revenues Decline 68 Print Issue 68 M d yyyy 68 Announces Private Placement 68 Completes Initial 68 Option Grants 68 Review Initiated 68 Record Second Quarter 68 Q3 Loss Narrows 68 Declares Distribution 68 Provides Updates 67 Files Shelf Registration Statement 67 Announces Shareholder Approval 67 Completes Tender Offer 67 MITTEILUNG UEBERMITTELT VON BUSINESS 67 Share Repurchases 67 Opns 67 Announces Share Repurchase 67 Increases Quarterly Cash Dividend 67 Announces Normal Course 67 Stock Buyback 67 Drilling Underway 67 Declares Increased 67 Q1 Loss Narrows 67 Payable Date Jan 67 Q2 Loss Widens 67 Announces Monthly Distribution 67 Q2 Loss Narrows 67 Record Third Quarter 67 #.#/Share [002] 66 Secures Financing 66 Amends Credit 66 Announces Stockholder Approval 66 Announces Cash Dividend 66 Updates Guidance 66 Flow Through Offering 66 3rd Quarter Results 66 Flow Through Private Placement 66 Convertible Debt 66 Declares Monthly Dividend 66 Guidance Quick Facts 66 Joins OTCQX 66 Preliminary Third Quarter 66 Provides Guidance 66 Stockholders Approve 66 2nd Quarter Results 66 Q4 Loss Widens 66 Stockholders Approve Merger 66 Updates Status 66 Announce Completion 66 Common Share Dividend 66 Announces Successful Completion 66 Dividend Increase 66 Commences Trading 66 Q3 Loss Widens 65 .# Per Share 65 Q4 Loss Narrows 65 Shareholder Approval 65 EEO Public File 65 Explore Strategic Alternatives 65 Q1 Loss Widens 65 Warrant Exercise 65 CA BUSINESS 65 Forecast Quick Facts 65 Announces Issuance 65 Updates Shareholders 65 #/Share 65 Exelixis Announces 65 Dividend Payment